In vivo imaging of oligonucleotide delivery

Methods in Molecular Biology

Volumn 872, Issue , 2012, Pages 243-253

  Takeshita, Fumitaka ^a   Takahashi, Ryou U ^a   Onodera, Jun ^a   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer; Delivery; Imaging; Luciferase; MicroRNA; Oligonucleotides; siRNA

Indexed keywords

ATELOCOLLAGEN; SMALL INTERFERING RNA; MICRORNA; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG TARGETING; FLUORESCENCE IMAGING; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOGENICITY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE; SKIN TUMOR; ANIMAL; DIAGNOSTIC IMAGING; HUMAN; METHODOLOGY; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; HUMANS; MICE; MICE, NUDE; MICRORNAS; OLIGONUCLEOTIDES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84867604628     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-797-2_17     Document Type: Article

References (29)

1. Bass, B.L. (2000) Double-stranded RNA as a template for gene silencing. Cell 101 , 235-238.
2. Mcmanus, M.T. and Sharp, P.A. (2003) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3 , 737-747.
3. Shankar, P.; Manjunath, N.; Lieberman, J. (2005) The prospect of silencing disease using RNA interference. JAMA 293 , 1367-1373.
4. Leung, R.K.; Whittaker, P.A. (2005) RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther 107 , 222-239.
5. Behlke, M.A. (2006) Progress towards in vivo use of siRNAs. Mol Ther 13 , 644-670.
6. Dykxhoorn, D.M.; Palliser, D.; Lieberman, J. (2006) The silent treatment: siRNAs as small molecule drugs. Gene Ther 13 , 541-552.
7. Rayburn, E.R.; Wang, H.; Zhang, R. (2006) Antisense-based cancer therapeutics: are we there yet? Expert Opin Emerg Drugs 11 , 337-352.
8. Hagan, J.P. and Croce, C.M. (2007) MicroRNAs in carcinogenesis. Cytogenet Genome Res 118 , 252-259.
9. Jiang, J.; Gusev, Y.; Aderca, I.; Mettler, T.A.; Nagorney, D.M.; Brackett, D.J.; Roberts, L.R.; Schmittgen, T.D. (2008) Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14 , 419-427
10. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 , 281-297.
11. Osaki, M.; Takeshita, F.; Ochiya, T. (2008) MicroRNA as biomarkers and therapeutic drugs in human cancer. Biomarkers 13 , 658-670.
12. Minakuchi, Y.; Takeshita, F.; Kosaka, N.; Sasaki, H.; Yamamoto, Y.; Kouno, M.; Honma, K.; Nagahara, S.; Hanai, K.; Sano, A.; Kato, T.; Terada, M.; Ochiya, T. (2004) Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 32 :e109.
13. Takeshita, F.; Minakuchi, Y.; Nagahara, S.; Honma, K.; Sasaki, H.; Hirai, K.; Teratani, T.; Namatame, N.; Yamamoto, Y.; Hanai, K.; Kato, T.; Sano, A.; Ochiya, T. (2005) Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 102 , 12177-12182.
14. Honma, K.; Iwao-Koizumi, K.; Takeshita, F.; Yamamoto, Y.; Yoshida, T.; Nishio, K.; Nagahara, S.; Kato, K.; Ochiya, T. (2008) RPN2 gene confers docetaxel resistance in breast cancer. Nat Med 14 , 939-948.
15. Takei, Y.; Kadomatsu, K.; Goto, T.; Muramatsu, T. (2006) Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Cancer , 107 , 864-873.
16. Vooijs, M.; Jonkers, J.; Lyons, S.; Berns, A. (2002) Cancer Res 62, 1862-1867.
17. Hoffman, R.M. (1999) Orthotopic transplant mouse models with green fluorescent proteinexpressing cancer cells to visualize metastasis and angiogenesis. Cancer and Metastasis Reviews 17 , 271-277.
18. Hoffman, R.M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17 , 343-359.
19. Hoffman, R.M. (2002) In vivo imaging of metastatic cancer with fluorescent proteins. Cell Death Differ 9 , 786-789.
20. Hoffman, R.M. (2005) Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Methods Mol Med 111 , 297-322.
21. Nakanishi, H.; Ito, S.; Mochizuki, Y.; Tatematsu, M. (2005) Evaluation of chemosensitivity of micrometastases with green fluorescent protein gene-tagged tumor models in mice. Methods Mol Med 111 , 351-362.
22. Hennig, R.; Ventura, J.; Segersverd, R.; Ward, E.; Ding, X.Z.; Rao, S.M.; Jovanovic, B.D.; Iwamura, T.; Talamonti, M.S.; Bell, R.H. Jr, and Adrian, T.E. (2005) LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia 7 , 417-425.
23. Contag, P.R.; Olomu, I.N.; Stevenson, D.K.; Contag, C.H. (1998) Bioluminescent indicators in living mammals. Nat Med 4 , 245-247.
24. Rehemtulla, A.; Stegman, L.D.; Cardozo, S.J.; Gupta, S.; Hall, D.E.; Contag, C.H.; Ross, B.D. (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2 , 491-495.
25. Jenkins, DE, Oei, Y, Hornig, YS, Yu, S.F.; Dusich, J.; Purchio, T.; Contag, P.R. (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20 , 733-744.
26. Vooijs, M.; Jonkers, J.; Lyons, S.; Bernes, A. (2002) Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 62 , 1862-1867.
27. Lyons, S.K. (2005) Advances in imaging mouse tumor models in vivo. J Pathol 205 ,194-205.
28. Laurie, N.A.; Gray, J.K.; Zhang, J.; Leggas, M.; Relling, M.; Egorin, M.; Stewart, C.; Dyer, M.A. (2005) Topotecan combination chemotherapy in two new rodent models of retinobrastoma. Clin Cancer Res 11 , 7569-7578.
29. Takeshita, F.; Bader, A.G.; Osaki, M.; Takahashi, R.; Yamamoto, Y.; Kosaka, N.; Kawamata, M.; Kelnar, K.; Brown, D.; Ochiya, T. (2010) Systemic delivery of miR-16 for RNAi therapy in prostate cancer. Mol Ther 18 , 181-187.